🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/11/1991 | 21,89 | 22,54 | 21,75 | 22,44 | +3,01% | 3,63% | 8.883.686 |
| 15/11/1991 | 22,96 | 22,98 | 21,79 | 21,79 | -5,27% | 5,20% | 6.409.987 |
| 14/11/1991 | 22,72 | 23,00 | 22,70 | 23,00 | +1,49% | 1,31% | 5.625.245 |
| 13/11/1991 | 22,19 | 22,66 | 22,05 | 22,66 | +1,97% | 2,78% | 5.495.083 |
| 12/11/1991 | 21,79 | 22,26 | 21,69 | 22,22 | +3,14% | 2,65% | 4.385.880 |
| 11/11/1991 | 21,63 | 21,69 | 21,55 | 21,55 | -0,46% | 0,64% | 3.090.552 |
| 08/11/1991 | 22,03 | 22,11 | 21,61 | 21,65 | -0,91% | 2,26% | 4.190.952 |
| 07/11/1991 | 21,87 | 21,87 | 21,39 | 21,85 | +0,00% | 2,18% | 4.290.931 |
| 06/11/1991 | 21,99 | 22,11 | 21,71 | 21,85 | -0,45% | 1,81% | 3.232.032 |
| 05/11/1991 | 21,81 | 22,15 | 21,79 | 21,95 | +0,73% | 1,64% | 3.225.744 |
| 04/11/1991 | 21,57 | 21,81 | 21,51 | 21,79 | +0,55% | 1,38% | 2.370.576 |
| 01/11/1991 | 21,75 | 21,97 | 21,57 | 21,67 | -0,73% | 1,83% | 4.131.845 |
| 31/10/1991 | 21,11 | 21,83 | 21,11 | 21,83 | +3,10% | 3,39% | 3.739.474 |
| 30/10/1991 | 21,19 | 21,25 | 20,97 | 21,17 | -0,19% | 1,31% | 2.988.058 |
| 29/10/1991 | 21,35 | 21,37 | 21,07 | 21,21 | -0,65% | 1,40% | 3.514.992 |
| 28/10/1991 | 20,87 | 21,35 | 20,79 | 21,35 | +2,68% | 2,67% | 2.521.488 |
| 25/10/1991 | 21,09 | 21,23 | 20,77 | 20,79 | -1,32% | 2,17% | 3.182.986 |
| 24/10/1991 | 21,05 | 21,09 | 20,83 | 21,07 | +0,09% | 1,23% | 2.703.211 |
| 23/10/1991 | 20,75 | 21,05 | 20,73 | 21,05 | +1,44% | 1,53% | 3.080.491 |
| 22/10/1991 | 20,91 | 21,07 | 20,65 | 20,75 | -0,76% | 2,00% | 2.908.200 |
| 21/10/1991 | 20,99 | 21,05 | 20,79 | 20,91 | -0,38% | 1,23% | 2.505.139 |
| 18/10/1991 | 20,73 | 20,99 | 20,69 | 20,99 | +1,54% | 1,44% | 4.426.752 |
| 17/10/1991 | 20,73 | 20,79 | 20,65 | 20,67 | -0,57% | 0,67% | 3.186.130 |
| 16/10/1991 | 20,79 | 20,91 | 20,71 | 20,79 | +0,00% | 0,96% | 2.518.973 |
| 15/10/1991 | 20,73 | 20,91 | 20,63 | 20,79 | +0,29% | 1,34% | 2.925.806 |
| 14/10/1991 | 20,46 | 20,73 | 20,46 | 20,73 | +1,16% | 1,36% | 2.766.091 |
| 11/10/1991 | 20,28 | 20,50 | 20,16 | 20,50 | +1,08% | 1,67% | 3.776.573 |
| 10/10/1991 | 20,28 | 20,34 | 20,16 | 20,28 | +0,00% | 0,88% | 3.623.146 |
| 09/10/1991 | 20,28 | 20,38 | 20,26 | 20,28 | -0,49% | 0,59% | 3.238.320 |
| 08/10/1991 | 20,36 | 20,46 | 20,34 | 20,38 | +0,10% | 0,59% | 2.484.389 |